Upcoming Clinical Trial Presentation - Stocks of the Day

Stocks of the Day

Sign In / Sign Up

Latest News
Stock Screener
AI Signals
News Archive
Membership
About
- About
- FAQ
- Blog
- Contact Us

Home
Latest News
Stock Screener
AI Signals
News Archive
Membership
About
- About
- FAQ
- Blog
- Contact Us

Register Free
Sign in

Search mobile

Topic :

Upcoming Clinical Trial Presentation

GRCL, NASDAQ

#Cancer #Investor Conference #Trending News #Upcoming Clinical Trial Presentation

Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences

November 23, 2022
08:00

EST

SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Nov. 23, 2022 /PRNewswire/ — Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that the management team will participate in

No Comments

NASDAQ, RAIN

#Cancer #Featured #Trending News #Upcoming Clinical Trial Presentation

Rain Therapeutics Announces a Poster Presentation at the 2022 San Antonio Breast Cancer Symposium

November 23, 2022
08:00

EST

NEWARK, Calif., Nov. 23, 2022 (GLOBE NEWSWIRE) — Rain Therapeutics Inc. (NasdaqGS: RAIN), (Rain), a late-stage biotechnology company developing precision oncology therapeutics with a lead product candidate, milademetan, an oral, small molecule inhibitor of the MDM2-p53 complex that reactivates p53, today announced a poster presentation at the upcoming 2022

No Comments

ACIU, NASDAQ

#Alzheimer #Trending News #Upcoming Clinical Trial Presentation

AC Immune to Present Progress of Alzheimer’s Disease Programs targeting Abeta and Tau at the 15th CTAD Conference

November 23, 2022
07:30

EST

Next generation SupraAntigen® liposomal vaccine platform augments immunization against pathological targets of Alzheimer’s disease New data on anti-phospho-Tau vaccines confirm safety, tolerability and immunogenicity of ACI-35 and JACI-35, developed in collaboration with Janssen Pharmaceuticals Collaboration partner Genentech/Roche to present pharmacodynamic effects of semorinemab on plasma and CSF Tau biomarkers

No Comments

NASDAQ, STRO

#Investor Conference #Trending News #Upcoming Clinical Trial Presentation

Sutro Biopharma to Participate in Upcoming Investor Conferences

November 23, 2022
07:00

EST

SOUTH SAN FRANCISCO, Calif., Nov. 23, 2022 (GLOBE NEWSWIRE) — Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that Bill Newell, Chief Executive Officer, will participate in two upcoming investor conferences. Presentation Details: Piper

No Comments

AVXL, NASDAQ

#Alzheimer #Financial Report Scheduled #Upcoming Clinical Trial Presentation

Anavex Life Sciences to Announce Fiscal 2022 Year End Financial Results on Monday November 28, 2022

November 23, 2022
07:00

EST

NEW YORK, Nov. 23, 2022 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today announced

No Comments

NASDAQ, RGNX

#Investor Conference #Upcoming Clinical Trial Presentation

REGENXBIO to Participate in Upcoming Investor Conferences

November 22, 2022
07:05

EST

ROCKVILLE, Md., Nov. 22, 2022 /PRNewswire/ — REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following upcoming investor conferences: Piper Sandler 34th Annual Healthcare ConferencePresentation Date: Thursday, December 1, 2022Presentation Time: 9:10 a.m. ETLocation: Lotte New York Palace, New York, NY BofA Securities 2022 Virtual Biotech SMID

No Comments

AIH, NASDAQ

#Financial Report Scheduled #Upcoming Clinical Trial Presentation

Aesthetic Medical International to Announce Third Quarter 2022 Unaudited Financial Results on November 29, 2022

November 22, 2022
07:00

EST

SHENZHEN, China, Nov. 22, 2022 (GLOBE NEWSWIRE) — Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that it will release its unaudited financial results for the third quarter of 2022 before the U.S. market

No Comments

JANX, NASDAQ

#Investor Conference #Trending News #Upcoming Clinical Trial Presentation

Janux Therapeutics to Present at Upcoming Investor Conferences in November

November 22, 2022
06:00

EST

SAN DIEGO–(BUSINESS WIRE)–Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms, today announced that Janux management will present at two upcoming investor

No Comments

NASDAQ, ONCY

#Cancer #Trending News #Upcoming Clinical Trial Presentation

Oncolytics Biotech® Announces Presentations at the Upcoming San Antonio Breast Cancer Symposium

November 21, 2022
09:01

EST

SAN DIEGO and CALGARY, AB, Nov. 21, 2022 /PRNewswire/ — Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced the publication of two abstracts for poster presentations at the upcoming San Antonio Breast Cancer Symposium (SABCS), to be held at the Henry B. González Convention Center in San Antonio, Texas

No Comments

MIRM, NASDAQ

#Investor Conference #Liver #Upcoming Clinical Trial Presentation

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences

November 18, 2022
08:50

EST

FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will participate in the following upcoming investor conferences: Evercore ISI HealthCONx Conference on Tuesday, November 29, 2022.

No Comments

< Page1 Page2 Page3 … Page76 >

Trending News

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

11/25/2022

Natuzzi S.p.A.: Third Quarter 2022 Financial Results and Shareholder Letter

11/25/2022

Boxed, Inc. Announces Receipt of Continued Listing Standard Notice from NYSE

11/25/2022

Volta Inc. Receives Notice from NYSE Regarding Trading Share Price Listing Rule

11/25/2022

IMV Receives Nasdaq Notification Regarding Market Value of Listed Securities

11/25/2022

Most read news

The J.M. Smucker Co. Announces Fiscal 2023 Second Quarter Results

11/21/2022

Nobel Withdraws From Option to Acquire La Salvadora Copper Project in Chile

11/24/2022

Strong Technical Services Launches New Content Management Service

11/21/2022

© 2022 stocksoftheday.

Stocks of the Day does not provide investment advice. All rights reserved.

Tools

Predictions
Stock Screener
News Archive
News Feed
News Tags
Tickers
Trending Tickers
News Sentiments
Holidays & Trading Hours

Learn

FAQ
Guides
Infographics
Affiliate Program FAQ

Account

Sign In
Register
Email Preferences
Membership Option

Company

About
Contact Us
Careers
Blog
Privacy Policy
Terms of Use
Sitemap

Partnerships

Affiliate Program
Partnerships

Create account

Let the news trading begin!

Continue with Google

Continue with Facebook

Continue with Reddit

Continue with Discord

or

First Name

Last Name

Email

Password

I agree with the Terms of Use and Privacy Policy.

Already have an account?

Sign In

Let the news trading begin!

Continue with Google

Continue with Facebook

Continue with Reddit

Continue with Discord

or

Email

Password

Remember me

Lost your password?

Not registered yet?

Create a free account

Sign In

Let the news trading begin!

Continue with Google

Continue with Facebook

Continue with Reddit

Continue with Discord

or

Email

Password

Remember me

Lost your password?

Not registered yet?

Create a free account